Cargando…
Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry‐based study
AIM: The aim of this study was to investigate whether a disease registry could serve as a suitable alternative to clinical studies to investigate safety of orphan drugs in children. METHODS: We used individual patient data from previously untreated patients (PUPs) with severe haemophilia A from the...
Autores principales: | Jonker, Carla J., Oude Rengerink, Katrien, Hoes, Arno W., Mol, Peter G. M., van den Berg, H. Marijke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586966/ https://www.ncbi.nlm.nih.gov/pubmed/32627880 http://dx.doi.org/10.1111/hae.14100 |
Ejemplares similares
-
Registries supporting new drug applications
por: Jonker, Carla J., et al.
Publicado: (2017) -
Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders
por: Jonker, Carla J., et al.
Publicado: (2021) -
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study
por: Liesner, Ri J., et al.
Publicado: (2021) -
Experience of Advate rAHF-PFM in previously untreated patients and minimally treated patients with haemophilia A
por: Auerswald, Guenter, et al.
Publicado: (2012) -
Pregnant womens’ concerns when invited to a randomized trial: a qualitative case control study
por: Oude Rengerink, Katrien, et al.
Publicado: (2015)